CG 3rd Annual I&I Disease Symposium: Fibrotic Lung Disease - IPF & PPF

Join us virtually for a morning event of moderated panels consisting of private and public companies focused on drug development in the immunology & inflammation space, and with KOLs focused on treating these conditions. Our focus for this symposium will be on fibrotic lung diseases, specifically progressive pulmonary
fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF). We look to discuss current therapy gaps, emerging treatments, and the pulmonologist’s need for new options.

For more information, contact Nadine Miller at nmiller@cgf.com